Page 10 - 2021 Winter CMTA Report
P. 10

Advances in Genetics:


                         New Tools for Prospective Families



                         BY CHRISTINE MURRAY, MD

                                dvances in genetic tech-  disorder. Huntington’s disease  are more common among certain
                                nology have allowed for  and Marfan syndrome are exam-    populations. Comprehensive car-
                                the development of       ples of autosomal dominant       rier screening panels now test
                                powerful tools to assist  inheritance. X and Y chromo-    for nearly 300 single-gene
                         A people as they begin to       somes can also carry genetic     defects. The American College of
                         plan their families. Multiple   mutations: Hemophilia and frag-  Obstetrics and Gynecology rec-
                         techniques are available to pro-  ile X syndrome have an X-linked  ommends that women have
                         vide prospective parents with   inheritance pattern.             genetic carrier screening as part
                         valuable information to plan and    The Human Genome Project,    of their routine prenatal evalua-
                         prepare. This overview, while not  a multinational scientific collab-  tion. Reproductive options for
                         comprehensive, offers a look into  oration completed in 2003, is  at-risk couples include IVF with
                         what modern genetic analysis    widely considered one of the     preimplantation genetic testing
                         can do.                         most ambitious scientific under-  (PGT), conception with donor
                             A review of basic genetics  takings of all time. The finished  eggs or sperm or adoption.
                         provides a good starting point.  project sequenced 3 billion DNA
                         Human beings have cells con-    letters covering 99 percent of the  NON-INVASIVE PRENATAL
                         taining 46 chromosomes: Two     human gene-containing regions.   TESTING/SCREENING
                         will code for gender at birth (X    It is hard to overstate the  NiPT is a genetic test that is per-
                         and Y). The remaining 22 auto-  tremendous impact of this under-  formed once pregnancy has been
                         some pairs consist of maternal  taking. The results have been    established. It requires a simple
                         and paternal DNA. These paired  used to identify a genetic source  blood draw and can be done as
                         chromosomes contain hundreds    for a multitude of medical issues,  early as nine to 10 weeks of preg-
                         of thousands of DNA strands—    including cancers, as arising from  nancy. The test analyzes tiny
                         genes that code for all the traits  specific mutations. Understand-  fragments of cell-free DNA from
                         that make us who we are.        ing the genetic basis of disease  the developing placenta to assess
                         Defects in any of these genes can  opens the door for specific diag-  the genetic health of the devel-
                         lead to specific disorders. Such  nostic tools and treatments.   oping baby.
                         single-gene mutations can be                                        Unlike carrier screening,
                         inherited in an autosomal reces-  GENETIC CARRIER                which provides information
                         sive manner, which means that   SCREENING                        about specific genes, NiPT is
                         an affected child received one  Carrier screening refers to a    used to detect chromosomal dis-
                         defective gene from each parent.   blood test that can identify silent  orders that are caused by the
                             The parents, each having    gene mutations. Prospective par-  presence of an extra or missing
                         only one affected gene, are con-  ents are now routinely offered  copy (aneuploidy) of a chromo-
                         sidered silent carriers and are  this screening to identify some of  some. NiPT primarily looks for
                         not affected by the disorder.   the most common mutations like   trisomy 21 (Down syndrome),
                         Their offspring has a 25 percent  the genes for cystic fibrosis (CF),  caused by an extra chromosome
                         chance of having the disorder   spinal muscular atrophy and      at position 21, trisomy 13 and 18
                         and a 50 percent chance of being  fragile X syndrome. This basic  and extra or missing copies of
                         a silent carrier.               carrier panel is offered to one  the X and Y chromosome. NiPT
                             Examples of autosomal       potential parent. If a silent    can also identify gender. NiPT is
                         recessive disorders are cystic  mutation is identified, the other  a screening test, which means
                         fibrosis, sickle cell anemia and  parent is tested. There are    that it cannot give a definitive
                         spinal muscular atrophy. Some   expanded panels recommended      answer about whether the preg-
                         disorders are autosomal domi-   for parents based on their ethnic  nancy is affected. The test can
                         nant—inheriting only one        backgrounds. Tay Sachs, sickle   only estimate whether the risk of
                         abnormal gene will lead to the  cell anemia and the thalassemias  having certain conditions is

      10  THE CMTA REPORT  WINTER 2021
   5   6   7   8   9   10   11   12   13   14   15